Clin2
NCT06680869Possibly a fitRecruiting

Early amiodarone for shockable cardiac arrest

Cardiac Arrest

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether giving the heart rhythm medicine amiodarone early after a shockable cardiac arrest improves survival. If you had a cardiac arrest due to a heart rhythm problem that didn't stop after the first shock, this study may be for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
585 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had a cardiac arrest that was not caused by an injury
  • The first heart rhythm emergency workers saw was ventricular fibrillation or ventricular tachycardia
  • The abnormal rhythm came back or didn't stop after the first defibrillator shock
  • You are not allergic to the study drug amiodarone
  • You do not have a 'do not resuscitate' order

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06672159Recruiting
Double shock for out-of-hospital cardiac arrest

This trial tests a new way of giving two quick shocks to restart the heart in people who have a cardiac arrest outside the hospital. If you had a shockable heart rhythm, this approach might help improve your chances of survival.

Trondheim
NCT06203847Recruiting
Prehospital drug combo for cardiac arrest

This trial tests whether a combination of three medications (epinephrine, vasopressin, and a steroid) given by paramedics before arriving at the hospital can improve survival for adults who have a cardiac arrest outside of a hospital. It is only for patients who are treated by specially trained paramedics and meet specific medical criteria.

Taipei
NCT06835491Recruiting· Phase 3
Amiodarone to prevent heart rhythm problems after cardiac arrest

This trial tests whether giving the drug amiodarone early can prevent dangerous heart rhythm problems in patients who survived a cardiac arrest with a shockable rhythm. If it works, it could help more people recover.

Amiens
NCT07273994Recruiting· Phase 4
Comparing two amiodarone doses after heart shock treatment for atrial fibrillation

This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).

Barcelona
NCT06645249Not yet recruiting· Phase 4
Amiodarone before electrical cardioversion for persistent atrial fibrillation

This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.

Badalona
NCT07818785Not yet recruiting
Shock settings for cardiac arrest treated by emergency responders

This study compares different ways to use a defibrillator (a device that delivers an electric shock to restart the heart) when someone has a cardiac arrest outside a hospital. It aims to find the best approach to improve survival.

Hear when a new Cardiac Arrest trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.